HealthGuard - Britacel Successful Partnership Offering Solutions To Combat COVID-19

All over the world a lot of research is happening, across industries to come out with solutions to tackle the situation arising out of the Covid -19 pandemic. The spotlight in the textile industry has been on the recent developments in the field of antimicrobial treatment and related solutions. Australia based HealthGuard Corporation has been in the forefront of such initiatives and has been a name that has been constantly making the headlines for its Antimicrobial solutions in recent times. The company with three decades of expertise in non-invasive health care products has now joined hands with Britacel Silicones Ltd, India, who are considered pioneers in finishing chemicals with a global presence.

Going into details regarding the nature of partnership in an exclusive chat, Dr. Christopher Harvey, Chairman of HealthGuard Corporation, mentioned that while HealthGuard will be handling the technical, production and compliance part, Britacel Silicones will be taking care of the global marketing, distribution, application and technical support services.

While HealthGuard’s Office & production base is Melbourne, Britacel Silicones has got 3 manufacturing units located in Goa & Head office in Mumbai.

HealthGuard AMIC

HealthGuard had recently announced the test results of HealthGuard AMIC treated textiles against human strain Covid-19 (SARS COV 2).

“The results are astounding. After 10 minutes exposure to HealthGuard AMIC treated substrate the Human Strain of Covid-19 virus recorded a 99.9% reduction in viral activity. Further time delay testing at 60 minutes and 120 minutes, were even more astonishing, after 60 minutes and 120 minutes exposure the Covid-19 virus was certified as non-detectable. This once again exhibits that HealthGuard AMIC is the market-leading anti-Covid-19 treatment for textiles,” Mr. Harvey said.